Jellyfish have repeatedly riddled the world of marine biology with its toughest mysteries. The immortal jellyfish might be the biggest one so far.
getty
Aging is biology’s most reliable law. Every organism that has ever lived, from the oldest known tree to the longest-lived vertebrate on record, has obeyed it. Cells accumulate damage. Tissues lose function. Death eventually follows. The universality of this process is so complete that biologists have spent decades not asking whether aging can be stopped, but simply trying to understand why it happens at all. The immortal jellyfish (Turritopsis dohrnii), however, raises the former once again.
Smaller than the nail on your little finger, about 4.5 millimeters (0.17 inches) across, this transparent hydrozoan drifts through the world’s oceans with a bright red stomach visible through its belly and up to 90 tentacles trailing behind it. It’s easy to miss, and for most of the 20th century, science did. But T. dohrnii possesses something that no other animal on Earth is known to possess: the ability to reverse its own biological age. Not slow it. Not pause it. Reverse it — repeatedly, and apparently without limit.
It’s the only known metazoan capable of doing this. And the more closely scientists have looked at how, the more it has begun to challenge assumptions about what aging actually is.
To understand what makes T. dohrnii extraordinary, it helps to understand what it shares with every other jellyfish. Like all hydrozoans, it begins life as a microscopic planula larva, drifting briefly in open water before settling on the seafloor and developing into a colonial polyp — a small, anchored structure that looks nothing like what we recognize as a jellyfish.
From that polyp colony, free-swimming medusae bud off and develop into mature adults within a matter of weeks. This is, broadly speaking, the standard hydrozoan blueprint. Most species follow it to its conclusion: the medusa reproduces, ages and dies. For the immortal jellyfish, it does not.
When a mature medusa is subjected to sufficient stress (e.g., starvation, physical injury, disease, cellular deterioration, etc.), something unusual begins to happen. Rather than dying, the animal retracts its tentacles, reabsorbs its bell and sinks. It collapses inward into an unstructured mass of tissue, what researchers have termed the cyst stage, before reorganizing entirely and emerging as a functional polyp once more. In other words, the clock resets.
This process, first documented in a 1996 study from The Biological Bulletin, is not metaphorical rejuvenation. It is a literal whole-body transformation, confirmed by electron microscopy, in which fully differentiated adult cells (i.e., cells that had already committed to becoming muscle, nerve or epithelial tissue) abandon that commitment entirely and take on new identities.
The technical term for this is transdifferentiation, and it is deeply unusual in the animal kingdom. In most organisms, cellular differentiation is a one-way road; a muscle cell becomes a muscle cell and stays one. The developmental biology of virtually every animal we study is built on that assumption of irreversibility. T. dohrnii challenges that assumption.
For decades, the cellular mechanics of this reversal remained poorly understood. That changed substantially in a 2022 genomic study published in the Proceedings of the National Academy of Sciences, presenting the first complete whole-genome comparison between T. dohrnii and its closest mortal relative, T. rubra — a near-identical species that cannot rejuvenate.
The differences were striking. T. dohrnii carried roughly double the number of genes associated with DNA repair and protection found in T. rubra. It showed marked expansions in genes governing telomere maintenance: the molecular machinery that protects the ends of chromosomes from degrading with each round of cell division, a process central to how most organisms age at the cellular level.
Genes regulating stem cell populations, redox balance and cell-to-cell communication were also expanded or distinctly modified. And during life cycle reversal itself, the transcriptomic data revealed something almost theatrical: developmental genes that had been expressed at the polyp stage reactivated, as though the animal’s genome were running a restoration from an earlier save point. This tells us that T. dohrnii has an integrated genomic toolkit, built over evolutionary time for precisely this kind of cellular reset.
Earlier transcriptomic work had already offered a clue about what that toolkit contains. Analyzing gene expression across the major stages of T. dohrnii’s life cycle, they identified elevated activity in a set of reprogramming factors that biologists know well from a very different context: the Yamanaka factors — Oct4, Sox2, Klf4 and c-Myc — the same transcription factors that Shinya Yamanaka used to reprogram adult human cells into induced pluripotent stem cells, which earned him the Nobel Prize in 2012.
The fact that T. dohrnii appears to deploy a version of this same molecular strategy during its own cellular reprogramming suggests that the capacity for dedifferentiation may be far more ancient and conserved across animal life than we have appreciated. It suggests that T. dohrnii has simply retained and elaborated it, whereas most other lineages lost it.
It’s important to clarify that T. dohrnii is not immortal in any practical sense. It can be eaten. It can be killed by disease, by pollution, by injury severe enough to prevent reversal. Maintaining the species in a laboratory setting requires intensive daily care; few researchers have managed it successfully over the long term.
Instead, what the biology actually supports is a more precise claim: that in the absence of external mortality pressures, T. dohrnii appears capable of cycling through its life history indefinitely. Whether any individual ever achieves that in nature is an open question. The immortality is theoretical. The biology behind it is not.
The honest answer to “what does this mean for human aging” is: we don’t know yet. T. dohrnii is not a pharmaceutical lead. Its biology will not translate into a therapy on any near-term timescale. Anyone promising otherwise is selling something.
But the organism poses a question that aging research has not previously had to answer in quite this form: if cellular senescence can be reversed — that is, if a fully differentiated adult cell can be induced to abandon its identity and begin again — then aging is not simply an accumulation of damage that biology lacks the tools to address. It’s a problem that evolution has already solved, at least once, in at least one lineage.
The most scientifically significant puzzle T. dohrnii presents is not the reversal itself, but how it accomplishes that reversal without triggering runaway cell proliferation. In human cells, the kind of dedifferentiation that T. dohrnii performs routinely is precisely the sort of process associated with oncogenesis. Reprogramming cells is not difficult; cancer does it constantly. The challenge is doing it in a controlled, coordinated, organism-wide fashion that produces a functional animal rather than a tumor. T. dohrnii has an answer to that problem. We do not yet know what it is.
That, more than any promise of human immortality, is what makes this animal worth studying. It has navigated a biological problem that sits at the intersection of aging, regeneration and cancer, three of the most consequential research areas in modern biology, and it has done so with a genome we can now read in full.
As sequencing technologies improve and more laboratories succeed in culturing the species reliably, the next decade of T. dohrnii research may not tell us how to live forever. But it may tell us something more useful: precisely why we age at all.
While the immortal jellyfish evokes our wonder and curiosity, the deep sea and its creatures can often stir a deep, primal fear in us. Take my science-backed Thalassophobia Test to know if you have a particularly pronounced fear of deep waters.
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。